Fourth quarter 2021 UPNEEQ product sales of $3.1 million, representing 39% growth over third quarter sales Fourth quarter and full year 2021 total revenues of $2.9 million and $17.5 million, ...
BRIDGEWATER, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”) announced today that its prescription eye drop Upneeq® (oxymetazoline ...
Upneeq (oxymetazoline) is a brand-name eye drop that’s prescribed for droopy eyelids in adults. The cost of the drug with and without insurance can depend on several factors. Specifically, Upneeq is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results